Carisma Therapeutics Inc. Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities
Carisma Therapeutics Inc. had Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities of $3.50 million as of 2023-03-07, per its 10-K filed 2025-03-31.
Financial Statements › Notes › Business Combination, Asset Acquisition, Transaction between Entities under Common Control, and Joint Venture Formation › Business Combination, Recognized Asset Acquired to Liability Assumed, Excess (Less), and Goodwill › Business Combination, Recognized Asset Acquired to Liability Assumed, Excess (Less)
us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilities · last filed 2025-03-31
- 2023-03-07: Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities $3.50M.
| Period end | Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities |
|---|---|
| 2023-03-07 | $3.50M 10-K · filed 2025-03-31 |